Author

L. Bumba

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:E. coli· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Fraudeau· 1 shared B. Gallet· 1 shared C. Liesche· 1 shared C. Moriscot· 1 shared D. Kuzmenko· 1 shared E. Kandiah· 1 shared F. Barras· 1 shared F. Rebeille· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Fraudeau

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The AAA+ ATPase RavA and its binding partner ViaA modulate E. coli aminoglycoside sensitivity through interaction with the inner membrane

J. Felix, L. Bumba, C. Liesche, A. Fraudeau, F. Rebeille, J. El Khoury, K. Huard, B. Gallet, C. Moriscot, J.-P. Kleman, Y. Duhoo, M. Jessop, E. Kandiah, F. Barras, J. Jouhet, I. Gutsche

This study identifies RavA and ViaA as modulators of E. coli aminoglycoside sensitivity through lipid interactions affecting membrane morphology and antibiotic resistance.

bioRxiv · Feb 6, 2022Microbiology

Lipid binding by N-terminal motif mediates plasma membrane localization of Bordetella effector protein BteA

I. Malcova, L. Bumba, F. Uljanic, D. Kuzmenko, J. Nedomova, J. Kamanova

This paper identifies the mechanism by which BteA effector protein targets the plasma membrane via its N-terminal LRT domain, showing that lipid binding is not required for cytotoxicity.

bioRxiv · Nov 17, 2020Microbiology